ARS Pharmaceuticals Inc (SPRY) stock saw a decline, ending the day at $14.77 which represents a decrease of $-0.09 or -0.61% from the prior close of $14.86. The stock opened at $14.97 and touched a ...
Whether it’s allergies, a sinus infection or runny nose, many people turn to nasal sprays for quick relief. Now, there’s ...
We came across a bullish thesis on ARS Pharmaceuticals (SPRY) on Value Degen’s Substack by Unemployed Value Degen. In this ...
ARS Pharmaceuticals Inc (SPRY) stock saw a modest uptick, ending the day at $14.05 which represents a slight increase of $1.00 or 7.66% from the prior close of $13.05. The stock opened at $13.1 and ...
Credit: ARS Pharmaceuticals. Neffy is indicated for adult and pediatric patients weighing at least 30kg. It is recommended that patients be prescribed and have immediate access to 2 neffy nasal sprays ...
Hosted on MSN18d
ARS Pharmaceuticals, Inc. (SPRY) Upgraded to Buy: Here's WhyARS Pharmaceuticals, Inc. (SPRY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates ...
ARS Pharmaceuticals Inc. submitted a supplemental New Drug Application (sNDA) for a1 mg dose of nasal spray neffy, to treat ...
The maker of a homeopathic nasal spray with a history of contamination is refusing to recall its product after the Food and ...
The submission of the neffy 1 mg sNDA follows the FDA approval of neffy (2 mg) on August 9, 2024, for treating Type I Allergic Reactions, including anaphylaxis, in adults and children weighing 30 kg ...
Richard Lowenthal, Co-Founder, President and CEO of ARS Pharma and Eric Karas, Chief Commercial Officer of ARS Pharma will participate in a fireside chat on Tuesday, September 17, 2024, at 9:10 a.m.
NDAQ:SPRY) ARS Pharmaceuticals, Inc. Is Being Looked Into For Violating Securities Laws And The Schall Law Firm Urges Investors To Reach Out ...
圣地亚哥 - 生物制药公司ARS Pharmaceuticals, Inc. (NASDAQ: SPRY)宣布,其处方药neffy®(肾上腺素鼻喷剂)现已在全美上市。美国食品药品监督管理局(FDA)上月批准了用于治疗体重超过30公斤(66磅)个体I型过敏反应(包括过敏性休克)的2毫克neffy。 通过neffyConnect项目和与在线药房BlinkRx的合作,符合条件的商业保险患者可以25美元的 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback